Home
Drug Development
Boehringer Ingelheim and IBM Canada Announce First of its Kind Collaboration to Integrate Blockchain Technology into Clinical Trials

AbbVie and Teneobio Announce a Strategic Transaction to Develop a New Treatment for Multiple Myeloma

U.S. FDA Approves DARZALEX Split-Dosing Regimen

EC Approves ADCETRIS with AVD, the First New Treatment in Decades for Adults with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma

EC Approves Bristol-Myers Squibb’s Sprycel in Combination with Chemotherapy for Treatment of Pediatric Patients

Samsung Bioepis and C-Bridge Capital to Develop and Commercialize Next-Generation Biosimilars in China

US FDA grants Breakthrough Therapy Designation for potential next-generation RSV medicine MEDI8897

Solentim and ATUM announce technology collaboration to enable rapid, high expression, stable cell line development

AstraZeneca collaborates with Aptamer Group on next-gen drug delivery devices
Manufacturing
Supply Chain
Facilities
Health & Nutrition
Events
Contact Us

No Result

View All Result

No Result

View All Result

No Result

View All Result

bioLIVE China 2019 to be Newly Upgraded, to Lead the Development of the Bio-Pharma Technology in Asia

bioLIVE China 2019 to be Newly Upgraded, to Lead the Development of the Bio-Pharma Technology in Asia

by Content Team 11th January 2019

Exact Sciences and Pfizer Enter into U.S. Promotion Agreement for Cologuard®

by Content Team 29th August 2018

Drug Development

Daiichi Sankyo Launches NaruveinⓇ Injection for Cancer Pain Treatment in Japan

by Content Team 24th May 2018

Clinical Trials

Teva Announces Publication of Phase III Trial Data of Fremanezumab for the Preventive Treatment of Episodic Migraine in the Journal of the American Medical Association

by Content Team 21st May 2018

Chemspec Europe 2018:Introduction of Partnering Programme adds new level of networking

by Content Team 22nd March 2018

Lilly, Livongo team up for real-world diabetes research, aiming for better results in an outcomes-oriented market

by Content Team 13th February 2018

Clinical Trials

Chinese researchers report first lung stem cell transplantation clinical trial

by Content Team 13th February 2018

Drug Development

Using injectable self-assembled nanomaterials for sustained delivery of drugs Drug

by Content Team 13th February 2018

bioLIVE China 2019 to be Newly Upgraded, to Lead the Development of the Bio-Pharma Technology in Asia

Latest News

Boehringer Ingelheim and IBM Canada Announce First of its Kind Collaboration to Integrate Blockchain Technology into Clinical Trials

Clinical Trials

Boehringer Ingelheim and IBM Canada Announce First of its Kind Collaboration to Integrate Blockchain Technology into Clinical Trials

by Content Team

13th February 2019

Boehringer Ingelheim and IBM Canada announced at the Healthcare Information and Management Systems Society (HIMSS) conference in Orlando, Florida, their ...

Drug Development

AbbVie and Teneobio Announce a Strategic Transaction to Develop a New Treatment for Multiple Myeloma

13th February 2019

U.S. FDA Approves DARZALEX Split-Dosing Regimen

13th February 2019

EC Approves ADCETRIS with AVD, the First New Treatment in Decades for Adults with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma

12th February 2019

EC Approves Bristol-Myers Squibb’s Sprycel in Combination with Chemotherapy for Treatment of Pediatric Patients

12th February 2019

Samsung Bioepis and C-Bridge Capital to Develop and Commercialize Next-Generation Biosimilars in China

Samsung Bioepis and C-Bridge Capital to Develop and Commercialize Next-Generation Biosimilars in China

12th February 2019

US FDA grants Breakthrough Therapy Designation for potential next-generation RSV medicine MEDI8897

US FDA grants Breakthrough Therapy Designation for potential next-generation RSV medicine MEDI8897

8th February 2019

Solentim and ATUM announce technology collaboration to enable rapid, high expression, stable cell line development

Solentim and ATUM announce technology collaboration to enable rapid, high expression, stable cell line development

8th February 2019

Markets & Financial Moves

Aldeyra Therapeutics Expands Retinal Disease Pipeline with Acquisition of Helio Vision

Drug Development

Aldeyra Therapeutics Expands Retinal Disease Pipeline with Acquisition of Helio Vision

by Content Team

30th January 2019

Aldeyra Therapeutics, Inc. , a biotechnology company devoted to developing and commercializing next-generation medicines to improve the lives of patients...

Bristol-Myers Squibb to acquire Celgene in $74bn deal

Bristol-Myers Squibb to acquire Celgene in $74bn deal

4th January 2019

Arsanis and X4 Pharmaceuticals enter into a definitive merger agreement

Arsanis and X4 Pharmaceuticals enter into a definitive merger agreement

30th November 2018

Allergan to Acquire Bonti Adding New Neurotoxin Programs to Medical Aesthetics Pipeline

19th September 2018

Novo Nordisk acquires Ziylo Ltd to accelerate its development of glucose responsive insulins

17th August 2018

Herbalife Nutrition Announces the Adjusted Price Range of Its Dutch Auction Tender Offer for Common Shares Following Stock-Split

Baxter Reports First-Quarter 2018 Results and Increases Financial Outlook for Full-Year 2018

Alexion Reports First Quarter 2018 Results And Positive Topline Data From ALXN1210 Phase 3 PNH Switch Study

Partners Pharmacy completes Acquisition of Presbyterian Village North Pharmacy

22nd March 2018

White Papers

Most Read

Boehringer Ingelheim and IBM Canada Announce First of its Kind Collaboration to Integrate Blockchain Technology into Clinical Trials

Clinical Trials

Boehringer Ingelheim and IBM Canada Announce First of its Kind Collaboration to Integrate Blockchain Technology into Clinical Trials

13th February 2019

WuXi Biologics and Amicus Sign Exclusive Manufacturing Partnership

WuXi Biologics and Amicus Sign Exclusive Manufacturing Partnership

13th February 2019

Most Popular

AbbVie and Teneobio Announce a Strategic Transaction to Develop a New Treatment for Multiple Myeloma

AbbVie and Teneobio Announce a Strategic Transaction to Develop a New Treatment for Multiple Myeloma

13th February 2019

U.S. FDA Approves DARZALEX Split-Dosing Regimen

U.S. FDA Approves DARZALEX Split-Dosing Regimen

13th February 2019

Press Statements

Packaging & Logistics

Boehringer Ingelheim and IBM Canada Announce First of its Kind Collaboration to Integrate Blockchain Technology into Clinical Trials

Clinical Trials

Boehringer Ingelheim and IBM Canada Announce First of its Kind Collaboration to Integrate Blockchain Technology into Clinical Trials

13th February 2019

WuXi Biologics and Amicus Sign Exclusive Manufacturing Partnership

WuXi Biologics and Amicus Sign Exclusive Manufacturing Partnership

13th February 2019

AbbVie and Teneobio Announce a Strategic Transaction to Develop a New Treatment for Multiple Myeloma

Drug Development

AbbVie and Teneobio Announce a Strategic Transaction to Develop a New Treatment for Multiple Myeloma

13th February 2019

U.S. FDA Approves DARZALEX Split-Dosing Regimen

U.S. FDA Approves DARZALEX Split-Dosing Regimen

13th February 2019

EC Approves ADCETRIS with AVD, the First New Treatment in Decades for Adults with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma

EC Approves ADCETRIS with AVD, the First New Treatment in Decades for Adults with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma

12th February 2019

EC Approves Bristol-Myers Squibb’s Sprycel in Combination with Chemotherapy for Treatment of Pediatric Patients

EC Approves Bristol-Myers Squibb’s Sprycel in Combination with Chemotherapy for Treatment of Pediatric Patients

12th February 2019

Ompi and SiO2 Medical Products sign collaboration agreement

Ompi and SiO2 Medical Products sign collaboration agreement

12th February 2019

Samsung Bioepis and C-Bridge Capital to Develop and Commercialize Next-Generation Biosimilars in China

Drug Development

Samsung Bioepis and C-Bridge Capital to Develop and Commercialize Next-Generation Biosimilars in China

12th February 2019

US FDA grants Breakthrough Therapy Designation for potential next-generation RSV medicine MEDI8897

US FDA grants Breakthrough Therapy Designation for potential next-generation RSV medicine MEDI8897

8th February 2019

Video Channel

Currently Playing

SAS Drug Development for Small/Midsize Pharmaceutical & Biotech

SAS Drug Development for Small/Midsize Pharmaceutical & Biotech

packaging automation for pharma industry

Drug Development

Research & Development

Astellas and KM Biologics Expiration of Distribution Agreement for Human Vaccines, etc. and Blood Plasma Products

Press Statements

Astellas and KM Biologics Expiration of Distribution Agreement for Human Vaccines, etc. and Blood Plasma Products

by Content Team

24th January 2019

Press Statements

SIRIO Pharma opens multimillion gummy production plant at new high-tech nutraceutical facility in Ma’anshan, China

by Content Team

12th November 2018

RetiPharma Secures Funding to Develop Treatments of Degenerative Eye Disorders

Drug Development

RetiPharma Secures Funding to Develop Treatments of Degenerative Eye Disorders

by Content Team

13th October 2018

Clinical Trials

Boehringer Ingelheim and IBM Canada Announce First of its Kind Collaboration to Integrate Blockchain Technology into Clinical Trials

Boehringer Ingelheim and IBM Canada Announce First of its Kind Collaboration to Integrate Blockchain Technology into Clinical Trials

13th February 2019

NeuroBo Pharmaceuticals to Initiate Phase III Clinical Trial of NB-01 in Adult Patients with Diabetic Neuropathic Pain

NeuroBo Pharmaceuticals to Initiate Phase III Clinical Trial of NB-01 in Adult Patients with Diabetic Neuropathic Pain

22nd January 2019

Bluebird bio and Celgene Corporation Present Initial Data from Phase 1 Clinical Study of Next-Generation Anti-BCMA CAR T Cell Therapy

Bluebird bio and Celgene Corporation Present Initial Data from Phase 1 Clinical Study of Next-Generation Anti-BCMA CAR T Cell Therapy

6th December 2018

QPS Expands U.S.-Based Phase I Clinical Trial Capabilities to Support the Growing Needs of Its Pharmaceutical, Biotechnology and CRO Partners

QPS Expands U.S.-Based Phase I Clinical Trial Capabilities to Support the Growing Needs of Its Pharmaceutical, Biotechnology and CRO Partners

5th December 2018

AMAL Therapeutics raises CHF 33.2 Million Series B Round

AMAL Therapeutics raises CHF 33.2 Million Series B Round

30th November 2018

AMAL Therapeutics raises CHF 33.2 Million Series B Round

13th November 2018

Regulatory Approvals

U.S. FDA Approves DARZALEX Split-Dosing Regimen

U.S. FDA Approves DARZALEX Split-Dosing Regimen

13th February 2019

EC Approves ADCETRIS with AVD, the First New Treatment in Decades for Adults with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma

EC Approves ADCETRIS with AVD, the First New Treatment in Decades for Adults with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma

12th February 2019

EC Approves Bristol-Myers Squibb’s Sprycel in Combination with Chemotherapy for Treatment of Pediatric Patients

EC Approves Bristol-Myers Squibb’s Sprycel in Combination with Chemotherapy for Treatment of Pediatric Patients

12th February 2019

US FDA grants Breakthrough Therapy Designation for potential next-generation RSV medicine MEDI8897

8th February 2019

Neovasc Receives Approval to Proceed with Phase 2 of TIARA-II Study from Clinical Regulators in Germany and the UK

30th January 2019

CStone receives CTA approval in China to start Phase I trial for FGFR4 inhibitor BLU-554 (CS3008)

30th January 2019

Amgen Receives NMPA Approval For Repatha In China To Reduce The Risk Of Cardiovascular Events

29th January 2019

Sanofi secures FDA approval for flu vaccine in children

29th January 2019

Chinas National Medical Products Administration Approves Harvoni for Treatment of Chronic Hepatitis C Virus Genotype

7th January 2019

Facilities

Sharp enhances clinical IRT solution with latest investment

Sharp enhances clinical IRT solution with latest investment

7th February 2019

SGS expands testing capabilities at Glasgow facility

SGS expands testing capabilities at Glasgow facility

30th January 2019

Almac Group Extends Personalized Cancer Vaccine Production Facilities

Almac Group Extends Personalized Cancer Vaccine Production Facilities

22nd January 2019

Grifols Expands its Blood Typing Solutions Portfolio in the United States with Antisera Reagents

Manufacturing

WuXi Biologics and Amicus Sign Exclusive Manufacturing Partnership

WuXi Biologics and Amicus Sign Exclusive Manufacturing Partnership

13th February 2019

AbbVie and Teneobio Announce a Strategic Transaction to Develop a New Treatment for Multiple Myeloma

AbbVie and Teneobio Announce a Strategic Transaction to Develop a New Treatment for Multiple Myeloma

13th February 2019

U.S. FDA Approves DARZALEX Split-Dosing Regimen

U.S. FDA Approves DARZALEX Split-Dosing Regimen

13th February 2019

EC Approves ADCETRIS with AVD, the First New Treatment in Decades for Adults with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma

EC Approves ADCETRIS with AVD, the First New Treatment in Decades for Adults with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma

12th February 2019

Events and Exhibitions

Health & Nutrition

GE Healthcare to open biotechnology manufacturing center in UK

Health & Nutrition

GE Healthcare to open biotechnology manufacturing center in UK

by Content Team

3rd December 2018

GE Healthcare announced the opening of a biotechnology manufacturing center at the Stevenage Bioscience Catalyst (SBC) Open Innovation Campus, in...

Nestle China accelerates innovation

Nestle China accelerates innovation

13th November 2018

GE increases cell culture media production capacity by tenfold

DSM invests to increase global Dyneema® production capacity

Natural History of Diabetes

9th February 2018

More News

IQVIA Launches IQVIA Biotech, Dedicated to Emerging Biotech and Biopharma Industry

by Content Team

8th February 2019

IQVIA Launches IQVIA Biotech, Dedicated to Emerging Biotech and Biopharma Industry

IQVIA announced the launch of IQVIA™ Biotech and its new approach to delivering tailored clinical and commercial solutions for small...

TrakCel, WindMIL Therapeutics Partner to Develop Supply Chain Platform

by Content Team

8th February 2019

TrakCel, WindMIL Therapeutics Partner to Develop Supply Chain Platform

TrakCel—a software developer for cell and gene therapy supply chain tracking and orchestration systems—and WindMIL Therapeutics—a clinical-stage oncology cell therapy...

Enzene Biosciences Chooses Novasep BioSC Pilot Chromatography for Its Automated End to End Continuous Manufacture of mAb

by Content Team

8th February 2019

Enzene Biosciences Chooses Novasep BioSC Pilot Chromatography for Its Automated End to End Continuous Manufacture of mAb

Novasep, a leading supplier of services and technologies for the life sciences industry, announces Enzene Biosciences (India) has chosen BioSC®...

AstraZeneca collaborates with Aptamer Group on next-gen drug delivery devices

by Content Team

8th February 2019

AstraZeneca collaborates with Aptamer Group on next-gen drug delivery devices

The two-year project will see Astrazeneca exploring the use of aptamer technology for targeted delivery of the kidney. Aptamers are...

Marken To Build New GMP-Compliant Facility In Philadelphia

by Content Team

8th February 2019

Marken To Build New GMP-Compliant Facility In Philadelphia

Marken announced the expansion of its facilities in Philadelphia to include more space for logistics operations as well as a...

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

Resources

System

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result

View All Result

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.